ES359842A1 - Un procedimiento para la preparacion de 4-oxa-androstanos. - Google Patents

Un procedimiento para la preparacion de 4-oxa-androstanos.

Info

Publication number
ES359842A1
ES359842A1 ES359842A ES359842A ES359842A1 ES 359842 A1 ES359842 A1 ES 359842A1 ES 359842 A ES359842 A ES 359842A ES 359842 A ES359842 A ES 359842A ES 359842 A1 ES359842 A1 ES 359842A1
Authority
ES
Spain
Prior art keywords
alpha
compounds
androstan
seco
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES359842A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES359842A1 publication Critical patent/ES359842A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • G—PHYSICS
    • G11—INFORMATION STORAGE
    • G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B33/00—Constructional parts, details or accessories not provided for in the other groups of this subclass
    • G11B33/02—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon
    • G11B33/04—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon modified to store record carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES359842A 1967-11-03 1968-11-02 Un procedimiento para la preparacion de 4-oxa-androstanos. Expired ES359842A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68030867A 1967-11-03 1967-11-03

Publications (1)

Publication Number Publication Date
ES359842A1 true ES359842A1 (es) 1970-06-16

Family

ID=24730576

Family Applications (1)

Application Number Title Priority Date Filing Date
ES359842A Expired ES359842A1 (es) 1967-11-03 1968-11-02 Un procedimiento para la preparacion de 4-oxa-androstanos.

Country Status (14)

Country Link
AT (2) AT297236B (fr)
BE (1) BE723189A (fr)
BR (1) BR6803654D0 (fr)
CH (1) CH505855A (fr)
DK (1) DK131576C (fr)
ES (1) ES359842A1 (fr)
FI (1) FI48098C (fr)
FR (2) FR1605466A (fr)
GB (1) GB1247022A (fr)
IE (1) IE33567B1 (fr)
IL (1) IL30879A (fr)
NL (1) NL6815623A (fr)
NO (1) NO132101C (fr)
SE (1) SE352360B (fr)

Also Published As

Publication number Publication date
NO132101B (fr) 1975-06-09
DE1805857A1 (de) 1969-06-26
FR8435M (fr) 1971-07-15
FR1605466A (fr) 1976-05-14
NO132101C (fr) 1975-09-17
DE1805857B2 (de) 1977-06-23
NL6815623A (fr) 1969-05-06
AT287932B (de) 1971-02-10
BR6803654D0 (pt) 1973-01-16
FI48098B (fr) 1974-02-28
BE723189A (fr) 1969-04-30
IL30879A (en) 1972-11-28
CH505855A (de) 1971-04-15
IE33567L (en) 1969-05-03
DK131576C (da) 1976-01-05
FI48098C (fi) 1974-06-10
IL30879A0 (en) 1968-12-26
GB1247022A (en) 1971-09-22
DK131576B (da) 1975-08-04
IE33567B1 (en) 1974-08-21
SE352360B (fr) 1972-12-27
AT297236B (de) 1972-03-10

Similar Documents

Publication Publication Date Title
GB1299333A (en) Preparation of carotenoid compounds
JPS543087A (en) Preparation of cephalosporin compound
GB1160477A (en) Hair-Fixative Compositions.
GB1415412A (en) Perfluoroalkyl compounds process for their manufacture and their use
GB1230630A (fr)
ES372835A1 (es) Un metodo para preparar esteres de acido cianoacetico.
GB1247022A (en) Novel 3,5-seco-a-nor-androstan-3-oic acids
GB1447351A (en) Process for producing alkoxymethylene malonic acid esters
ES425088A1 (es) Procedimiento para preparar resinas acidas.
JPS523046A (en) Prepration of 4-homotwistane-3-carboxylic acid esters
GB1298005A (fr)
GB1500396A (en) Diesters
JPS5334719A (en) Preparation of substituted or unsubstituted alpha-oxysuccinic acid esters
GB1472910A (en) 2-substituted adenosine-5-carboxylic acids and esters thereof
GB1353687A (en) Hexenoic compounds
GB1313903A (en) Phosphoric acid amide esters
GB1381570A (en) Perfluoroalkylsulphones
GB1107036A (en) Esters of dibenzocycloheptenyl-carboxylic acids
CA1028335A (fr) Methodes pour empecher la polymerisation des esters d'acides carboxyliques insatures et melanges stables
GB1005641A (en) Dihalocarbene addition products of unsaturated carboxylic acids
HU186353B (en) Insictecide agent consists of unsaturated carboxylic acid ester as actor
ES434933A1 (es) Procedimiento para la preparacion de composiciones perfu- mantes o sazonantes.
JPS5555140A (en) Manufacture of carboxylic acid ester of betaaformyllcrotylalcohol by alkyl rearrangement
ES267188A1 (es) Procedimiento para la obtencion de éteres de oxido oxidenzoico terapéuticamente valiosos y de sus sales
GB1136891A (en) Preparation of monomeric perfluoroalky esters of unsaturated acids